Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 2285-2291, December 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldin, A.

Factors Pertaining to Complete Drug-induced Remission of Tumor in Animals and Man

Abraham Goldin

Cancer Chemotherapy National Service Center, Chemotherapy, National Cancer Institute, Bethesda, Maryland 20014

Complete remission of tumor involves the elimination or the control of growth of the tumor cell population and is subject to a balance of factors pertaining to the drug, tumor, and host. Among the most notable variables which may influence the attainment of complete remission are the extent of action of the drug on the tumor cells, the drug toxicity for the host, the degree of challenge represented by the number of tumor cells, the origin and extent of tumor cell resistance, the degree of sequestration of the tumor cells, and the pharmacologic and immunologic status of the host.

In therapy, one or more of the factors pertaining to the host-tumor-drug relationship may become limiting, thereby preventing the chemotherapeutic agent from exerting sufficient effect at a tolerated dosage to achieve complete tumor remission. However, these limiting factors can be manipulated in favor of a net increase in chemotherapeutic specificity of action of the treatment against the tumor cells, and examples are cited of specific approaches worthy of further investigation and of potential chemotherapeutic value for the clinic.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.